Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion type Assertion NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_head.
- NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_provenance.
- NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion evidence source_evidence_literature NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_provenance.
- NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion SIO_000772 21399663 NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_provenance.
- NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion wasDerivedFrom befree-20140225 NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_provenance.
- NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion wasGeneratedBy ECO_0000203 NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_provenance.